On 19 February 2013, 24 EU member states signed a supra-national agreement which is intended to bring into being a new court called the Uniform Patent Court. This agreement, together with two EU Regulations, the Unitary Patent Regulation (1257/2012) and the Translations Regulation (1260/2012), will finally bring into being something akin to a Community Patent and a Community Patent Court. Neil Jenkins at Bird & Bird LLP explains that to appreciate the implications of this to industry, and in particular the pharmaceutical industry, it is absolutely critical to understand the nature of both the new patent right and the new court.

 

[prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2013/06/2-Some-Practical-Implications-of-the-UP-and-the-UPC-for-the-Pharmaceutical-Sector.pdf” type=”pdf”]Some Practical Implications of the UP and the UPC for the Pharmaceutical Sector[/prettyfilelink]

Comments are closed.

%d bloggers like this: